Nurix

Research Associate II/III- Bioanalytical/In Vitro ADME/DMPK

Nurix$92K — $124K *
Pharmaceuticals & Biotech
Less than 5 years of experience
Job Overview by Ladders

Qualifications

  • BS or Master’s degree with 4+ years in a discovery setting using LC-MS/MS
  • Extensive experience in bioanalytical assay development/sample analysis for small molecules
  • Expertise in different biological matrices including blood and plasma
  • Familiarity with AB SCIEX mass spectrometry software
  • Excellent written and verbal communication skills for collaboration in a matrix environment

Responsibilities

  • Provide bioanalytical support for PK and non-GLP safety studies
  • Conduct method development and qualification for drug and biomarker analysis
  • Independently develop and implement LC-MS/MS methods
  • Perform in vitro stability assays to assess drug metabolism
  • Utilize LC-QTOF MS/MS for metabolic identification and analysis
  • Operate, troubleshoot, and maintain LC-MS/MS systems
  • Collaborate with multidisciplinary teams to address bioanalytical needs
  • Manage CRO projects to ensure timely delivery of high-quality data

Benefits

  • Comprehensive health and wellness benefits
  • Opportunities for professional growth and development
  • Inclusive and collaborative work environment
  • Supportive organizational culture aligned with core values
Full Job Description
Position

Nurix Therapeutics is searching for a motivated Research Associate to join our Bioanalytical-In Vitro DMPK team. The successful candidate will contribute to the bioanalytical efforts to support Nurix drug discovery programs involving in vivo and in vitro studies. We are seeking a highly motivated research associate to characterize the in vitro and in vivo ADME properties of drug candidates. The primary responsibilities will be to conduct bioanalysis for in vivo samples and to conduct in vitro experiments. The scope of the daily responsibilities for this position includes, but is not limited to, developing bioanalytical methods, quantitating drug candidates and their metabolites, endogenous biomarkers in biological matrices (e.g. blood, plasma, tissue, tumor, CSF, etc.), reporting bioanalytical results and managing projects outsourced in CROs to support all in vitro and in vivo studies. The successful candidate will have extensive experience in bioanalytical method development and sample analysis using LC-MS/MS and other analytical techniques.

Key Responsibilities
  • Provide bioanalytical support for in-house PK, non-GLP safety TK
  • Conduct bioanalytical method development and qualification to support drug, metabolite and biomarker analysis
  • Independently develop LC-MS/MS methods to quantitate small molecules in in vitro and in vivo samples
  • Conduct in-vitro stability assays to understand metabolism of drugs
  • Perform metabolic identification (MetID) using LC-QTOF MS/MS, including accurate mass analysis, fragment interpretation and biotransformation pathway assignment
  • Independently operate, troubleshoot and maintain LC-MS/MS systems
  • Participate in multidisciplinary project teams and collaborate with other departments to understand bioanalytical needs for both PK and PD support
  • Manage projects conducted at CROs to ensure high quality bioanalytical data is delivered to meet project timelines
  • Maintain accurate and detailed scientific electronic laboratory notebooks
  • Perform all duties in keeping with the Company's core values, policies and all applicable regulations

Preferred Qualifications & Experience
  • Experience with H/UPLC and mass spectrometry
  • Good working knowledge of SCIEX LC-MS/MS systems for small molecule quantitation
  • PK analysis using Phoenix or other data management software
  • Management experience with CROs for outsourcing BA activities is preferred
  • Provide sample analysis to support PK, PK/PD, PK/efficacy, distribution, metabolism, and non-GLP toxicology studies
  • Identify issues and troubleshoot scientific equipment including LC-MS/MS, select and develop appropriate methods to perform experiments, analyze data and prepare related reports.
  • Excellent oral and written communication skills

Minimum Requirements
  • BS or master's with >4 years' experience working in a discovery setting using LC-MS/MS within a pharmaceutical/biotechnology company
  • Broad experience in small molecule drug candidate bioanalytical assay development/sample analysis in different biological matrices using LC-MS/MS
  • Experience with AB SCIEX mass spectrometry software
  • Excellent written, verbal communications and interpersonal skills to collaborate with internal and external partners in a matrix environment

Fit with Nurix Culture and Values
  • Strong team orientation; highly collaborative
  • Solutions and results-oriented focus
  • Hands-on approach; resourceful and open to diverse points of view

Location: Brisbane, CA - Onsite

Salary Ranges:

RA II $92,891 - $106,507

RA III $110,101 - $124,079

Application Process

Nurix is an Equal Opportunity Employer offering a competitive salary and benefits package. Applicants should be legally entitled to work for any employer in the US.

Note to Employment Agencies:Please do not forward any agency resumes. Nurix will not be responsible for fees related to unsolicited resumes.

Nurix Therapeutics, Inc. is committed to protecting and respecting your privacy and personal information, including information collected by Nurix when you apply for a job with Nurix or in the course of your employment with Nurix. By applying for a position at Nurix, you agree to our collection and use of personal information as described in our Privacy Policy (https://www.nurixtx.com/privacy-policy/).

About Nurix

Nurix Therapeutics is a biotechnology company that is focused on the discovery, development, and commercialization of small molecule therapies that modulate the ubiquitin proteasome system (UPS) for the treatment of cancer and other diseases. The company's proprietary drug discovery platform is based on the use of DNA-encoded libraries (DELs) to identify small molecules that selectively bind to E3 ligases, which are key enzymes in the UPS. Nurix's lead drug candidate, NX-2127, is a first-in-class small molecule inhibitor of the CBL-B E3 ligase that is being developed for the treatment of solid tumors and hematological malignancies. The company was founded in 2013 and is headquartered in San Francisco, California.
Learn more about Nurix
Size
135 employees
Market Cap
$486 million
Industry
Net Income
-$43.2 million
Founded
2009
Revenue
$17.8 million
NASDAQ

Similar Jobs

More Jobs at Nurix

More Pharmaceuticals & Biotech Jobs

Find similar Research Associate II/III- Bioanalytical/In Vitro ADME/DMPK jobs: